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GUEST EDITORIAL
Will Physicians and Scientists Have Any Role in Managing Laboratory
Resources in the Year 2000?
Matthew J. McQueen
Vice-President of the International Federation of Clinical Chemistry (IFCC)
Considering the question raised, the first answer is that
physicians and scientists will have no role if they are
still waiting to see what will be the changes in Labora-
tory Medicine and are wondering how to react. Unfortu-
nately, there are too many adherents to the passive ap-
proach. The second answer is that they will have a role
if they have already changed their way of thinking and
are currently constructing the future. Laboratory Medi-
cine is not suffering from a terminal illness but is experi-
encing the identity crisis of the adolescent.
From my point of view, we are confronted with
important challenges and problems:
The economic challenge
The crisis has been brought about by the economic chal-
lenge presented by the desire of governments in all parts
of the world to reduce the cost of health care. It is not a
radically new vision of health care that is being pre-
sented by health planners and economists. The economic
goals create the political climate necessary to justify the
reduced funding. Do more with less, but do not reduce
quality! This has arisen because of high consumer ex-
pectations for high-quality care, an ageing population
making more demands, and a tempting selection of new
and expensive technology.
The economic challenge is a many headed monster with
different heads devouring developed and developing
countries. No sooner has one head been cut-off than an-
other arises to cause more problems. In most developed
countries evidence based medicine is in vogue. How-
ever, economists and health policy analysts have a credi-
bility problem in demanding evidence from everyone
else while providing little evidence for their policies and
financial strategies. Warnings from physicians that the
drive for efficiency may harm patients can be down-
played by suggesting that this might be a familiar exer-
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cise in shroud waving by doctors and managers (1). In
healthcare we have been thrust into the biggest labora-
tory in the world and coerced to conduct a vast array of
uncontrolled experiments.
Consolidation, centralisation, downsizing, re-engineer-
ing, rationalisation, restructuring, are painfully familiar
terms and represent a list of lamentations for laboratory
medicine. The effects of these actions are being seen
rapidly in Canada and the United States, where the cuts
are real and deep. In the United Kingdom in May 1996
the Guardian Newspaper ran two articles (2, 3) about
financial problems in the National Health Service
(NHS). The first article reported that NHS hospital trusts
had met the Secretary-of-State for Health and warned of
severe financial difficulties facing trusts, including the
prospect of financial "meltdown".
Academic and service positions for laboratory
scientists and physicians
Some reports in the United States have suggested that
there will continue to be a reduction in laboratory posi-
tions (4, 5). In Canada a significant number of laboratory
scientists and physicians, particularly in Clinical Chem-
istry, have lost their jobs. Many retirements have not
been filled. Research budgets in industry in North Amer-
ica and Europe have been cut. All this means a reduction
in academic, service and industry positions for labora-
tory professionals. If anyone is currently saying that
their environment has not yet been hit by such problems,
it soon will be. Laboratory services are easy targets for
politicians and administrators. Removing beds or clin-
ical services frequently provokes public reaction. Cut-
ting laboratory services, or positions of scientists and
physicians who are being paid more than most health
care workers, brings tears only to the eyes of laboratory
staff and their families. We have not done a good job of
promoting our profession, or in providing evidence that
high quality laboratory work contributes to correct and
timely decisions to improve the quality of health care,
thus making better use of the existing and limited re-
sources.
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If laboratory physicians and scientists do not know
where they have come from, where they are now and
where they want to go, then someone else will lead
where we do not want to go. This will not be healthy for
the profession. The International Federation of Clinical
Chemistry (IFCC) Strategic Plah started as an idea in
1990, a difficult concept for a multicultural, multilingual
organisation. It began to emerge as a more coherent plan
in 1993-1994. The key element was to move from a
restricted, backward looking definition of Clinical
Chemistry and to define it as the application of chemi-
cal, molecular and cellular concepts and techniques to
the understanding and the evaluation of human health
and disease.
Your vision, your definition, your strategy for your own
environment must already be present or you are in trou-
ble concerning your future role. It is essential that in
the presence of management, education and technology
challenges, we never forget that Laboratory Medicine
(Pathology, in the broadest sense) is a clinical service.
Forget that and laboratory scientists and physicians will
have a very small role in the year 2000.
The c l in ica l challenge
Many scientific and medically qualified clinical chem-
ists are almost invisible in the clinical environment of
the hospital. Knowing theoretically the clinical rele-
vance and application of chemistry/biochemistry is not
enough in the hospital. The laboratory scientist has to
gain acceptance as a member of the medical staff.
Greater visibility, including rounds, comittees, "real"
consultation, demonstration of knowledge, self-market-
ing and self-promoting, will be judged chiefly in relation
to the clinical value they bring. More will be written
later about the additional clinical challenge facing the
laboratory physician.
For the laboratory scientist there is much wisdom in the
statement of the Athena Society that the clinical knowl-
edge and skills needed include physiology, pathophysi-
ology, molecular biology, microbiology, virology, immu-
nology, and coagulation/haemostasis (6). Clinical chem-
ists are already involved in non-traditional areas, includ-
ing automated haematology, thrombosis/haemostasis,
molecular biology, serology, and some aspects of micro-
biology. However, if this is only a technical involvement
there is no future. There needs to be clinical competence
and clinical value for meaningful and continued involve-
ment.
Knowledge will also be required in even less traditional
areas such as cytogenetics, pharmacology, epidemiol-
ogy, nutrition, environmental toxicology, genetics, and
anatomic pathology. There is a need to look beyond the
traditional and to embrace new insights and approaches
from other disciplines. Anatomic pathology is not a soli-
tude but it is an integral part of Laboratory Medicine. It
also needs to interact and realise that its high class
pattern recognition will be profoundly affected by ad-
vanced computerisation, advanced immunology, and
molecular diagnostics.
The challenge of new technology
Some of the evolutionary and revolutionary technologi-
cal changes occurring in scientific and engineering disci-
plines have been reviewed and presented (7, 8). The new
developments in advanced computers, micro-technol-
ogy, advanced immunodiagnostics, neural networks and
molecular biology, will continue to affect the type of
skilled professionals needed in the laboratory. Much of
the science will be handled by these sophisticated sys-
tems, while the practical and mundane steps in the diag-
nostic process will require fewer people. There will be
work for highly skilled managers and clinical consul-
tants who, if they want to remain relevant, will have
to be constantly aware of the emergence of these new
technologies and how to apply them in the laboratory to
enhance patient care. This means constant retraining. A
lack of awareness and adaptation will destroy our pro-
fession.
The management challenge
It is not sufficient for the laboratory to be a repository
of scientific, technical and clinical information. The
laboratory physicians and scientists must provide the
highest management skills for the maximum efficiency
and effectiveness of laboratory resources. Second rate
managers will not last long. Total Quality Management
(TQM) must be inculturated so that it is more than
an obscure management jargon. It includes resource
management, financial management and analysis, fo-
cusing on customers, team-building, understanding the
process from test requests through analysis to inter-
pretation and analysis of outcomes. All this is neces-
sary to maintain and evaluate the effectiveness of
the laboratory.
However, distinctions must be made between Directing
and Managing (9). Part of the weakness in laboratory
medicine was that it had become management top heavy,
and it is these layers which are currently being stripped
away. To "Direct" is to be expected to have vision which
encompasses the whole system, that sees new directions,
analyses opportunities, welcomes innovation and de-
cides on a course or direction, ensuring that managers
and all staff perform cost/benefit analysis, enhance turn-
around-time (TAT), utilise TQM and continuous quality
improvement, so that they perform to appropriate stan-
dards.
However, there are management skills which when cou-
pled with scientific and clinical understanding can make
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almost unchallengeable the role of laboratory scientists
and physicians. Expert Systems are new software appli-
cations that can have great effect in the hospital environ-
ment when programmed with the expertise and under-
standing of the skilled laboratory professional. With this
knowledge they might be used to suggest the most effi-
cient way to direct specimens through the laboratory,
how to optimise ordering and interpretation and inte-
grate this with the many other data points in the patient
record. Into this might be woven quality control, medi-
cal interpretation, biological validation and variation is-
sues.
Information systems and information exchange hold the
system together. We are and will continue to be judged
by how efficiently information goes through the system.
Knowing the potential and practical applications of in-
formation technology is added value from the laboratory
professional. This is the real challenge of modern com-
munication.
Appropriate utilisation is another challenge which can
enhance our relevance in the whole health care environ-
ment. It is not simply eliminating unnecessary tests but
also using many approaches to improve their interpreta-
tion and application, with the realisation that an expen-
sive test appropriately used may lead to greater savings
elsewhere in the system. We need to master this to be
the consultants we hear so much about, but which are
more myth than reality in the absence of these skills.
Improving turn-around-time is a necessary part of ap-
propriate utilisation. How many laboratory procedures
have been structured for the convenience of the labora-
tory rather than the customers? We have to ensure that
the right test is delivered, at the right time, to the right
person, at the right cost.
The education challenge
As we move towards the laboratory almost without
walls, we are demolishing the medieval castles of labo-
ratory medicine. Our response to the education chal-
lenge is the key as to how open our profession is to
change. The speed of change has removed the luxury of
thinking what we might do at some later date. Our rele-
vance now depends on what we are doing or have done
to respond to the education challenge.
The American Association for Clinical Chemistry
(AACC) has had the energy and vision to put together a
task force to identify the factors most likely to impact
and shape the future practice environment (10). They
identified 5 Core Competencies that will be necessary
for Clinical Chemists to practise successfully in the fu-
ture:
Firstly, the fundamental skills of having the training, ex-
pertise and experience required for certification in Clin-
ical Chemistry.
Secondly, the clinical skills to serve as consultants and
educators in the medical community.
Thirdly, the scientific and technical skills to assess ob-
jectively new technologies, understand and apply infor-
matics, take the lead in the introduction of new technol-
ogies and conduct appropriate research.
Fourthly, the management skills to develop strategic
business plans for resource management, process man-
agement, team building, team problem solving and
team leadership.
The final Core Competency is professional develop-
ment. This is career long continuing education, taking
part in professional organisations, sharing knowledge,
and maintaining expertise.
The AACC is giving priority to the clinical, scientific
and technical, and management skills.
These issues lead us to the training for the clinical
laboratory scientist. While there may be fewer in the
future, survival will be for the most highly qualified.
This has been addressed earlier when discussing
greater multi-disciplinary involvement of the scientist
with the blurring of distinctions between chemistry,
haematology, and microbiology, plus the difficulty if
not the impossibility of being a consultant without
better education in non-traditional areas. However, the
management challenge also means that there must be
training in information management, financial admin-
istrative management, training people to function ef-
fectively in committees and in the medical environ-
ment, together with the recognition that appropriate
utilisation cannot be achieved without basic medical
knowledge. All of us need better communication skills.
Training must reflect the broad based skills, yet many
training programs have not adjusted to this. We proba-
bly all recognise the vital importance of information
systems, yet in a survey published in 1995 only 4 to
5% of training time of residents and clinical chemists
was spent in information training (11).
Training for the laboratory physician
(cl inical and anatomic pathology)
There are major difficulties in trying to predict the
number of laboratory physicians required. There is need
for increased training in management and informatics,
and this is not being responded to appropriately in many
programs. The training and skills to foster appropriate
utilisation are not an integral part of current physician
training. Anatomic pathologists, who have traditionally
felt secure from many of die changes in laboratory medi-
cine, are not immune from the winds of change in our
health care climate. In many countries there is a retire-
ment bulge of laboratory physicians over the next few
years that will provide job opportunity but which will
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mask the problem that the number of academic and ser-
vice positions is decreasing because all will not be re-
placed. The anatomic pathologist is not being trained
to face the challenges of technology in the next 5 to
10 years.
Economically stressed hospital administrators will be
reluctant to employ laboratory physicians in Clinical
Pathology unless it is clear what added value they
bring. The skills and training issues outlined for the
scientists are relevant (12). However, in my view the
laboratory physician will survive only if there is a
clearly defined clinical or research role for that indivi-
dual, in addition to the more obvious laboratory ser-
vice component. Why would anyone pay more for a
physician if a scientist can fulfill the same role. The
clinical pathologist in chemistry, haematology, and mi-
crobiology will have to provide research activity and/
or they will have been trained to function as a clinical
specialist with appropriate clinical qualifications. These
areas will be the crucial added values to the laboratory
service component.
The challenge of basic and applied research
For all laboratory specialists there are training and re-
training issues for the present and the future. However,
while stressing skills we must not forget research. Eco-
nomic and market pressures have been diminishing the
time and resources available for research. We are not
doing enough to protect this vital component of our fu-
ture. To be competitive basic researchers need most of
their time protected for research. In applied research
there are still opportunities but laboratory directors in
their strategic planning need courage and support when
"downsizing" to be strong and protect the research envi-
ronment. This is a very difficult demand. Unless it is
faced courageously laboratory medicine as an academic
discipline will not be in the forefront of new ideas and
will not be producing the teachers for the next genera-
tion. Unimaginative approaches to reorganisation in var-
ious parts of North America have already reduced the
available academic talent.
The struggle for control
In the midst of all the challenges we cannot close our
eyes to politics and human nature. These are combined
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determine the future role.
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